Cheaper Drugs for Clinical Trials: New Access Rules for Researchers
This act aims to facilitate access to drugs and medical products for researchers conducting clinical trials. This will allow researchers to purchase necessary products at a lower price, potentially accelerating the development of new therapies and drugs, and influencing future treatment availability and costs.
Key points
Researchers conducting qualified research will be able to purchase drugs and medical products at a discounted price, reflecting production costs.
Drug manufacturers will be required to sell products to researchers who obtain approval from the relevant authority.
The act allows researchers to sue manufacturers who refuse to sell drugs at the discounted price, with potential remedies including a court order to sell and monetary damages.
Manufacturers will not be liable for damages resulting from researchers' improper use of the drugs.
Expired
Citizen Poll